Unlisted
| Company Name | 큐리옥스바이오시스템즈(주) |
| English Name | Curiox Biosystems Co., Ltd. |
| Business Reg. No. | 5238101156 |
| CEO | 김남용 |
| Address | 서울특별시 금천구 디지털로9길 41 2층 202호, 204호 ~ 213호 (가산동, 삼성아이티해링턴타워)   |
| Industry | 그 외 기타 의료용 기기 제조업 |
| Industry Code | 271 |
| Established | 20180907 |
| Phone | 02-2039-7160 |
| Website | curiox.co.kr/ |
| Regular Employees | 23persons |
| Corp. Reg. No. | 1101116865103 |
Venture Certified
| 벤처투자유형 | 2019-08-08 ~ 2021-08-07 | 20190300695 | 2019-08-08 |
| 벤처투자유형 | 2021-08-08 ~ 2024-08-07 | 20210909010005 | 2019-08-08 |
| 벤처투자유형 | 2024-08-08 ~ 2027-08-07 | 20240904010012 | 2019-08-08 |
Revenue CAGR -20.4%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 46B | 68B | 72B |
| Operating Profit | -134B | -106B | -114B |
| Net Profit | -81B | -100B | -115B |
| Total Assets | 706B | 578B | 486B |
| Total Liabilities | 219B | 49B | 48B |
| Total Equity | 486B | 529B | 439B |
Operating Loss: Op. profit -134B
Revenue down 32% YoY
3 Consecutive Years of Net Loss
Debt Ratio Surge (+36pp YoY)
▼ 34.6%
▼ 21.7%
▼ 86.1%
▲ 347.1%
▲ 26.4%
| Name | Position | Role | Comp. (M KRW) |
|---|---|---|---|
| 김남용 | 사내이사 | CEO | - |
| 정홍태 | 사내이사 | CFO | - |
| 장영수 | 사외이사 | 경영 자문 | - |
| 최종철 | 사외이사 | 경영자문 | - |
| 이현진 | 감사 | 감사 | - |
| 박성철 | 미등기 | 경영기획 | - |
| 박영호 | 미등기 | 생산총괄 | - |
| 노희준 | 미등기 | 연구소장 | - |
| Shareholder | Ownership (%) | Shares Held |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - |
| NPS Subscribers | 22persons |
| CEO | 김남용 |
| Est. Avg. Annual Salary | 4,96110K (41310K/mo) |
| Hired (12 mo) | +1persons |
| Left (12 mo) | -0persons |
| Net Change (12 mo) | +1persons |
| NPS Join Date | 2019-09-01 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
2 Additional Data Sources
{
"address": "서울 금천구",
"ceo_name": "김남용",
"certificate": [
{
"cert_number": "20190300695",
"changes": "",
"disclosure_date": "2019-08-08",
"first_cert_date": "2019-08-08",
"no": "1",
"type": "벤처투자유형",
"valid_period": "2019-08-08 ~ 2021-08-07"
},
{
"cert_number": "20210909010005",
"changes": "",
"disclosure_date": "2021-09-09",
"first_cert_date": "2019-08-08",
"no": "2",
"type": "벤처투자유형",
"valid_period": "2021-08-08 ~ 2024-08-07"
},
{
"cert_number": "20240904010012",
"changes": "",
"disclosure_date": "2024-09-04",
"first_cert_date": "2019-08-08",
"no": "3",
"type": "벤처투자유형",
"valid_period": "2024-08-08 ~ 2027-08-07"
}
],
"company_name": "큐리옥스바이오시스템즈 주식회사",
"financials": {
"2022": {
"capital_stock": 3284484000,
"cost_of_sales": 2733687000,
"current_assets": 13744540000,
"current_liabilities": 1272290000,
"gross_profit": 1241580000,
"net_income": -6321830000,
"net_income_bs": -6321830000,
"non_current_assets": 40250426000,
"non_current_liabilities": 36278000,
"non_operating_expenses": 2945483000,
"non_operating_income": 2981685000,
"operating_profit": -6358032000,
"revenue": 3975267000,
"sga_expenses": 7599612000,
"total_assets": 53994966000,
"total_equity": 52686399000,
"total_liabilities": 1308567000
},
"2023": {
"capital_stock": 4011246000,
"cost_of_sales": 2107377000,
"current_assets": 23561114000,
"current_liabilities": 1644414000,
"gross_profit": 1112837000,
"net_income": -6965582000,
"net_income_bs": -6965582000,
"non_current_assets": 41938457000,
"non_current_liabilities": 184468000,
"non_operating_expenses": 250041000,
"non_operating_income": 598152000,
"operating_profit": -7313693000,
"revenue": 3220214000,
"sga_expenses": 8426530000,
"total_assets": 65499571000,
"total_equity": 63670690000,
"total_liabilities": 1828881000
}
},
"industry": "그 외 기타 의료용 기기 제조업",
"investment": [
{
"amount": "2,000,000,000",
"changes": "2,000,000,000",
"date": "2024-07-26"
},
{
"amount": "2,279,000,000",
"changes": "2,279,000,000",
"date": "2019-09-27"
},
{
"amount": "3,445,000,000",
"changes": "3,445,000,000",
"date": "2019-08-14"
},
{
"amount": "3,445,000,000",
"changes": "3,445,000,000",
"date": "2019-07-12"
},
{
"amount": "3,445,000,000",
"changes": "3,445,000,000",
"date": "2019-07-12"
},
{
"amount": "2,279,000,000",
"changes": "2,279,000,000",
"date": "2019-07-09"
}
],
"phone": "02-2039-****",
"source": "pg_migration"
}{
"address": "서울특별시 금천구 디지털로9길",
"brno": "523810****",
"cappedWarning": false,
"companyName": "큐리옥스바이오시스템즈주식회사",
"estimatedAvgAnnualSalary": 49606392,
"estimatedAvgMonthlySalary": 4133866,
"fetchedAt": "2026-03-05T14:27:30.862Z",
"industryCode": "730003",
"industryName": "의학 및 약학 연구개발업",
"joinDate": "20190901",
"last12MonthsHired": 1,
"last12MonthsLeft": 0,
"last12MonthsNetChange": 1,
"leaveDate": null,
"monthlyPensionAmount": 8639780,
"monthlyTrend": [
{
"lostSubscribers": 0,
"newSubscribers": 1,
"yearMonth": null
}
],
"npsRateUsed": 0.095,
"npsUpperCap": 6370000,
"seq": "6809205",
"status": "1",
"styleCode": "1",
"subscriberCount": 22,
"turnoverMonths": 1
}Data Quality: 95/10 | Primary Source: Venture System | Section Coverage: 8/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | DART | Collected |
| Financial Statements | DART | Collected |
| Investment Metrics | DART | Collected |
| Officers | DART | Collected |
| Employment | DART | Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| Venture System Detail | 2026-03-05 | Collected |
| nps | 2026-03-05 | Collected |
| DART Financial | 2026-02-27 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |